Bunka Christopher
- SEC CIK
- 0001103780
No open-market purchases or sales filed in the past year.
Current role at each company
- LEXX Lexaria Bioscience Corp.Directoras of Mar 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bunka Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2025 (view filing) | Jul 29-30 | 1 day | Bunka ChristopherDirector | PPurchase | +27.5K | $0.9157 | +$25.2K | +10.8%281.9K after | 2 lots |
| Oct 18, 2022 (view filing) | Oct 12-13 | 6 days | Bunka ChristopherChief Executive Officer | PPurchase | +38.5K | $2.04 | +$78.4K | +17.8%254.4K after | Amended2 lots |